AmCad BioMed Corporation

Research AmCad BioMed Corporation (4188.TWO) on Bullrun: market cap TWD 911.99M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Ticker4188.TWO
ExchangeTWO
CountryTaiwan
SectorHealthcare
IndustryMedical Devices
CurrencyTWD
Market capTWD 911.99M
Financial periodQ2 2026
RevenueTWD 6.72M
Net income-TWD 15.11M
Free cash flow-TWD 13.51M
Gross margin36.8%

Valuation Snapshot

latest market cap is TWD 911.99M.

Valuation history

Year	Snapshot date	Market cap	P/E	Dividend yield	Annual dividend/share
2026	2026-10-18	TWD 911.99M	n/a	n/a	0

Dividend history

Latest trailing dividend snapshot: annual dividend/share 0 TWD.

About AmCad BioMed Corporation

AmCad BioMed Corporation develops computer-aided detection and diagnosis (CAD) software devices primarily in Taiwan. It offers products for early detection and diagnosis of various diseases. The company's products include AmCAD-UT Detection, a CAD device for ultrasound images of thyroid nodules; and AmCAD-UO for detection of obstructive sleep apnea on awake patients.

Related stock research

Taiwan stocks Taiwan Healthcare stocks A-Z stock index

Other Healthcare stocks

Apex Biotechnology Corp. (1733.TW) Health & Life Co., Ltd. (1781.TWO) Hi-Clearance Inc. (1788.TWO) Radiant Innovation Inc. (3373.TWO) Wellell Inc. (4106.TW) Rossmax International Ltd. (4121.TWO) United Orthopedic Corporation (4129.TWO) Dynamic Medical Technologies Inc. (4138.TWO) OK Biotech Co., Ltd. (4155.TW) Bioptik Technology Incorporation (4161.TWO) EPS Bio Technology Corp. (4183.TWO) S&S Healthcare Holding Ltd. (4198.TWO)

Frequently asked questions

What is AmCad BioMed Corporation's market cap?

AmCad BioMed Corporation's market capitalization is TWD 911.99M.